Skip to main content
Log in

A comparative SAR study of thrombin receptor derived non peptide mimetics: Importance of phenyl/guanidino proximity for activity

  • Full Papers
  • Published:
Amino Acids Aims and scope Submit manuscript

Summary

Thrombin, the most potent physiological platelet agonist interacts with cells through a specific G protein-coupled receptor which has been cloned and sequenced. Synthetic thrombin receptor peptides (TRAPS) comprising the first 5 amino acids (SFLLR and SFLLR-NH2) of the new N-terminus tethered ligand of the thrombin receptor that is generated by thrombin's proteolytic activity were found to cause full platelet aggregation. During the screening of novel thrombin receptor derived non-peptide mimetics in the platelet aggregation assay we found that 1-phenylacetyl-4-(6-guanidohexanoyl)-piperazine (1) and 1-(6-guanidohexanoyl)-4-(phenylacetylamidomethyl)-piperidine (2) exertedin vitro antagonist activities (56% and 40% correspondingly) as it is depicted by the platelet aggregation assay. Using Molecular Modeling, the synthetic compounds were overlayed with SFFLR. All three superimposed low energy structures had Phe and Arg aminoacids in spatial close proximity. The superimposition results revealed that1 resembled more the stereoelectronic environment of SFLLR than2. This difference may be related to their different antagonist efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adang A, Hermkens P, Linders J, Ottenheijm H, Staveren C (1994) Case histories of peptidomimetics: progression from peptides to drugs. J Royal Neth Chem Soc 113: 63–78

    Google Scholar 

  • Bahou W, Coller B, Potter C, Norton K, Kutok J, Goligorsky S (1993) The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation. J Clin Invest 91: 1405–1413

    Google Scholar 

  • Born G (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927–929

    Google Scholar 

  • Brass L, Ahuja M, Belmonte E, Pizarro S, Tarver A, Hoxie J (1994) The human platelet thrombin receptor. Turning it on and turning it off. Ann NY Acad Sci 714: 1–12

    Google Scholar 

  • Chao B, Kalkunte S, Maraganore J, Stone S (1992) Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor. Biochemistry 31: 6175–6178

    Google Scholar 

  • Coller B, Ward P, Ceruso M, Scudder L, Springer K, Kutok J, Prestwich G (1992) Thrombin receptor activating peptides; importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M. Biochemistry 31: 11713–11722

    Google Scholar 

  • Coughlin S (1993) Thrombin receptor structure and function. Thromb Haemostas 70: 184–187

    Google Scholar 

  • Glembotski C, Irons C, Krown K, Murray S, Sprenkle A, Sei C (1993) Myocardial alphathrombin receptor activation induces hypertrophy and increases atrial natriutic factor gene expression. J Biol Chem 268: 20646–20652

    Google Scholar 

  • Hui K, Jakubowski J, Wyss V, Angleton E (1992) Minimal sequence requirement of thrombin receptor agonist peptide. Biochem Biophys Res Commun 184: 790–796

    Google Scholar 

  • Matsoukas J, Panagiotopoulos D, Keramida M, Mavromoustakos T, Yamdagni R, Qiao W, Moore G, Saifeddine M, Hollenberg M (1996) Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity. J Med Chem 39: 3585–3591

    Google Scholar 

  • Matsoukas J, Hollenberg M, Mavromoustakos T, Panagiotopoulos D, Alexopoulos K, Yamdagni R, Wu Q, Moore G (1997) Conformational analysis of the thrombin receptor agonist peptides SFLLR and SFLLR-NH2 by NMR: evidence for cyclic bioactive conformation. J Prot Chem 16: 113–131

    Google Scholar 

  • Mavromoustakos T, De-Ping Y, Theodoropoulou E, Makriyiannis A (1995) Studies of the conformational properties of the cannabimimetic-aminoalkylindole pravadoline using NMR and molecular modeling. Eur J Med Chem 30: 227–234

    Google Scholar 

  • McNamara C, Sarembock I, Gimple L, Fenton J, Coughlin S, Owens G (1993) Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 91: 94–98

    Google Scholar 

  • Moore G, Smith J, Baylis B, Matsoukas J (1995) Design and pharmacology of peptide mimetics. Adv Pharmacol 33: 91–141

    Google Scholar 

  • Natarajan S, Riexinger D, Cambardella M, Seiler S (1995) “Tethered ligand” derived pentapeptide agonists of thrombin receptor: a study of side chain requirements for platelet aggregation. Int J Pept Protein Res 45: 145–151

    Google Scholar 

  • Panagiotopoulos D, Matsoukas J, Alexopoulos K, Zebeki A, Mavromoustakos T, Saifeddine M, Hollenberg M (1996) Synthesis and activities of cyclic thrombinreceptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence containing D-Phe and/or D-Arg. LiPS 3: 233–240

    Google Scholar 

  • Park T, McHowat J, Wolf R, Corr P (1994) Increased lysophosphatatidylcholine content induced by thrombin receptor stimulation in adult rabbit cardial ventricular myocytes. Cardiovasc Res 28: 1263–1268

    Google Scholar 

  • Rasmussen U, Gachet C, Schlessinger Y, Hanau D, Ohlmann P, Pouyssegur J, Van Obberghen-Schilling E, Cazanave J-P, Pavirani A (1993) A peptide ligand of the human thrombin receptor antagonizes thrombin and partially activates platelets. J Biol Chem 268: 14322–14328

    Google Scholar 

  • Rasmussen U, Vouret-Graviari V, Jallat S, Schlesinger Y, Pages G, Pavirani A, Lecocq JP, Pouyssegur J, Van Obberghen-Schilling E (1991) cDNA cloning and expression of a human α-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett 288: 123–128

    Google Scholar 

  • Scarborough R, Naughton M, Teng W, Hung D, Rose J, Vu T-K, Wheaton V, Turck C, Coughlin S (1992) Tethered ligand agonist peptides: structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem 267: 13146–13149

    Google Scholar 

  • Schwartz T (1994) Locating ligand-binding sites in 7TM receptors by protein engineering. Current Opin Biotechnol 5: 434–444

    Google Scholar 

  • Van Obberghen-Schilling E, Pouyssegur J (1993) Signalling pathways of the thrombin receptor. Thromb Haemostas 70: 163–167

    Google Scholar 

  • Vassallo R, Kieber-Emmons T, Cichowski K, Brass L (1992) Structure-function relationships in the activation of platelets thrombin receptors by receptor-derived peptides. J Biol Chem 267: 6081–6085

    Google Scholar 

  • Vu T-K, Hung D, Wheaton V, Coughlin S (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057–1068

    Google Scholar 

  • Zhong C, Hayzer D, Corson M, Runge M (1992) Tethered ligand agonist peptides: Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem 267: 16975–16979

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alexopoulos, K., Matsoukas, J., Tsehos, T. et al. A comparative SAR study of thrombin receptor derived non peptide mimetics: Importance of phenyl/guanidino proximity for activity. Amino Acids 15, 211–220 (1998). https://doi.org/10.1007/BF01318860

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01318860

Keywords

Navigation